Pharmacist-Led Interventions for Reducing Health Disparities: A Systematic Review

Author(s)

Mey SV1, Patel S2, Cordone CN1, Lukman G1, Sung JH1, Wang A1, Chan A1, Cadiz CL1, Hurley-Kim K1, Wisseh C1, Knox E1, Lee JYC1, Ozaki A1
1University of California-Irvine, Irvine, CA, USA, 2University of California-Irvine, El Centro, CA, USA

Presentation Documents

OBJECTIVES:

Health disparities exist in provision of and access to pharmacy services and medication management. Given a continued need to mitigate disparities in health outcomes, and the expanding body of literature regarding interventions to reduce health disparities, we conducted a systematic review to summarize worldwide pharmacist-led interventions that were designed to reduce health disparities, with the ultimate aim to provide guidance on future research directions to advance health equity.

METHODS:

PubMed, Scopus, and CINAHL were searched from inception to Oct/2021. Studies that evaluated pharmacist-delivered interventions aimed at reducing health disparities were included. Pilot or preliminary studies and publications in non-English language were excluded. Study characteristics, clinical areas, targeted patient population, and types of interventions and outcomes were evaluated.

RESULTS:

A total of 152 studies were included, of which 30.3% were randomized controlled trials. The majority of studies (82.9%) conducted in high-income countries targeted cardiometabolic conditions (52.4%). Infectious diseases were commonly managed conditions among studies (61.5%) conducted in middle/low-income countries. Most pharmacist-led interventions were delivered to patients that resided in rural areas (44.1%), followed by patients with low-income (32.9%) and patients of minority races/ethnicities (24.3%). A minimal number of studies (1.3%) reported gender-specific interventions, and no studies reported interventions directed at patients with disabilities. Multidisciplinary team care (71.1%) and medication management (61.2%) were the most prevalent care models reported among the studies. Commonly reported outcome measures included laboratory values (37.5%), medication utilization (27.3%) and medication adherence (17.1%). Only 7.9% and 9.9% of the studies reported humanistic and economic outcomes, respectively.

CONCLUSION

Pharmacists have led a variety of clinical interventions targeted toward a diverse range of patient populations, which unveiled pharmacists’ roles in reducing health disparities. Variability exists geographically and in certain groups for whom few interventions have been implemented, highlighting the need for further efforts to achieve equity in healthcare.

Conference/Value in Health Info

2022-05, ISPOR 2022, Washington, DC, USA

Value in Health, Volume 25, Issue 6, S1 (June 2022)

Code

HSD99

Disease

Cardiovascular Disorders, Diabetes/Endocrine/Metabolic Disorders, Infectious Disease (non-vaccine), Vaccines

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×